Inquiry form for Pending Clinical Trial on TDI 132 (Gilenya®)

Please complete the form below to be added to a distribution email list to receive information about the pending clinical trial of Gilenya® in ALS patients. Submission of information via this form does not in any way suggest access to or otherwise guarantee enrollment into this or any other clinical trial. You will receive a confirmation email upon completion with additional information. A webinar will be held on this topic in March. You will receive more information after completing the form below.